Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)

Kaiwen Wang; Jiangfeng Zhao; Zhiwei Chen; Ting Li; Xiaoming Tan; Yu Zheng; Liyang Gu; Li Guo; Fangfang Sun; Haiting Wang; Jiajie Li; Xiaodong Wang; Gabriela Riemekasten; Shuang Ye

doi:10.1093/rheumatology/key425

Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)

Kaiwen Wang, Jiangfeng Zhao, Zhiwei Chen, Ting Li, Xiaoming Tan, Yu Zheng, Liyang Gu, Li Guo, Fangfang Sun, Haiting Wang, Jiajie Li, Xiaodong Wang, Gabriela Riemekasten, Shuang Ye^*

^*Corresponding author for this work

Clinic of Rheumatology

Renji Hospital

3 Citations (Scopus)

Abstract

In the original article, corresponding author Shuang Ye's correspondence address listed the incorrect department. It should have read 'Department of Rheumatology'. This has now been corrected.

Original language	English
Journal	Rheumatology (United Kingdom)
Volume	58
Issue number	3
Pages (from-to)	557
Number of pages	1
ISSN	1462-0324
DOIs	https://doi.org/10.1093/rheumatology/key425
Publication status	Published - 01.03.2019

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/rheumatology/key425

Fingerprint

Dive into the research topics of 'Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)'. Together they form a unique fingerprint.

Cite this

Wang, K., Zhao, J., Chen, Z., Li, T., Tan, X., Zheng, Y., Gu, L., Guo, L., Sun, F., Wang, H., Li, J., Wang, X., Riemekasten, G., & Ye, S. (2019). Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341). Rheumatology (United Kingdom), 58(3), 557. https://doi.org/10.1093/rheumatology/key425

@article{436babc1b88c47b6b2cd6858364a999c,

title = "Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)",

abstract = "In the original article, corresponding author Shuang Ye's correspondence address listed the incorrect department. It should have read 'Department of Rheumatology'. This has now been corrected.",

author = "Kaiwen Wang and Jiangfeng Zhao and Zhiwei Chen and Ting Li and Xiaoming Tan and Yu Zheng and Liyang Gu and Li Guo and Fangfang Sun and Haiting Wang and Jiajie Li and Xiaodong Wang and Gabriela Riemekasten and Shuang Ye",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",

year = "2019",

month = mar,

day = "1",

doi = "10.1093/rheumatology/key425",

language = "English",

volume = "58",

pages = "557",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "3",

}

Wang, K, Zhao, J, Chen, Z, Li, T, Tan, X, Zheng, Y, Gu, L, Guo, L, Sun, F, Wang, H, Li, J, Wang, X, Riemekasten, G & Ye, S 2019, 'Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)', Rheumatology (United Kingdom), vol. 58, no. 3, pp. 557. https://doi.org/10.1093/rheumatology/key425

Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341). / Wang, Kaiwen; Zhao, Jiangfeng; Chen, Zhiwei et al.
In: Rheumatology (United Kingdom), Vol. 58, No. 3, 01.03.2019, p. 557.

Research output: Journal Articles › Comments/Debates

TY - JOUR

T1 - Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)

AU - Wang, Kaiwen

AU - Zhao, Jiangfeng

AU - Chen, Zhiwei

AU - Li, Ting

AU - Tan, Xiaoming

AU - Zheng, Yu

AU - Gu, Liyang

AU - Guo, Li

AU - Sun, Fangfang

AU - Wang, Haiting

AU - Li, Jiajie

AU - Wang, Xiaodong

AU - Riemekasten, Gabriela

AU - Ye, Shuang

N1 - Publisher Copyright: © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - In the original article, corresponding author Shuang Ye's correspondence address listed the incorrect department. It should have read 'Department of Rheumatology'. This has now been corrected.

AB - In the original article, corresponding author Shuang Ye's correspondence address listed the incorrect department. It should have read 'Department of Rheumatology'. This has now been corrected.

UR - https://www.scopus.com/pages/publications/85062525011

U2 - 10.1093/rheumatology/key425

DO - 10.1093/rheumatology/key425

M3 - Comments/Debates

C2 - 30590756

AN - SCOPUS:85062525011

SN - 1462-0324

VL - 58

SP - 557

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 3

ER -

Wang K, Zhao J, Chen Z, Li T, Tan X, Zheng Y et al. Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341). Rheumatology (United Kingdom). 2019 Mar 1;58(3):557. doi: 10.1093/rheumatology/key425

Corrigendum: CD4+ CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (Rheumatology (United Kingdom) (2019) 58 (511-521) DOI: 10.1093/rheumatology/key341)

Abstract

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this